Consumer watchdog petitions FDA for black box warning on Amgen's Prolia

Consumer watchdog petitions FDA for black box warning on Amgen's Prolia

Source: 
Fierce Pharma
snippet: 

The FDA has warned patients using Amgen’s osteoporosis drug Prolia that stopping treatment could lead to an increased risk of spinal fractures. Now, a consumer watchdog said the warnings haven’t gone far enough.